Zacks Investment Research upgraded shares of WALGREENS BAI (WBA) from UNDERPERFORM to NEUTRAL on January 07, 2015, with a target price of $75.70.
Walgreen Company is a national retail pharmacy chain and considered the leader in innovative drugstore retailing. Walgreens pioneered many store features that are becoming standards in the industry. Among those concepts are: Computerized pharmacies, Point-of-sale scanning, Freestanding stores with drive-thru pharmacies, and Intercom Plus, Walgreens advanced new pharmacy computer and workflow system. Intercom Plus allows pharmacists to spend more time counseling patients by assigning administrative tasks to pharmacy technicians
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on WALGREENS BAI (WBA),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment